LATEST NEWS
September 19, 2024 | Press Releases
Bavarian Nordic Receives EMA Approval of Mpox Vaccine for AdolescentsSeptember 12, 2024 | Press Releases
Bavarian Nordic Provides Update on the Mpox Vaccine Supply SituationSeptember 05, 2024 | Press Releases
First Doses of Bavarian Nordic’s Mpox Vaccine Now Arriving in the Democratic Republic of CongoAugust 27, 2024 | Press Releases
Bavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in SingaporeAugust 17, 2024 | Press Releases
Bavarian Nordic Provides Statement on Mpox Vaccine Supply and Collaboration with African and Global StakeholdersAugust 16, 2024 | Press Releases
Bavarian Nordic Submits Data to EMA to Extend Mpox/Smallpox Vaccine Approval to AdolescentsJuly 26, 2024 | Press Releases
Bavarian Nordic Receives Positive CHMP Opinion for Including Mpox Real-world Effectiveness Data in European Marketing Authorization for Smallpox and Mpox VaccineJuly 01, 2024 | Press Releases
Bavarian Nordic Converts Existing Credit Facility into Sustainability-linked LoanJune 28, 2024 | Press Releases
Bavarian Nordic Joins Global Efforts to Fight Mpox Outbreak in Africa May 30, 2024 | Press Releases
Bavarian Nordic and CEPI Partners to Advance Mpox Vaccination in Africa